Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mustapha Alani"'
Publikováno v:
Recent Patents on Anti-Cancer Drug Discovery. 13:308-340
Objective Mature T-cell lymphomas are a heterogeneous group of T-cell malignancies with a poor outcome. The discovery of new molecular biomarkers has led to the emergence of new drugs in recent years that target various signaling pathways. Methods We
Peripheral T-cell lymphoma (PTCL) is a heterogeneous group of clinically aggressive diseases associated with poor outcome. Despite progress in the last several years, resulting in a deeper understanding of the natural history and biology of PTCL base
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb8683ba6d31aeceef9e88207d04795b
https://europepmc.org/articles/PMC6192612/
https://europepmc.org/articles/PMC6192612/
Autor:
Kamel Laribi, Nathalie Denizon, Jonathan Farhi, Anne Besançon, Alix Baugier de Materre, Mustapha Alani, Habib Ghnaya
Publikováno v:
Leukemialymphoma. 59(11)
Autor:
Kamel Laribi, Alix Baugier de Materre, Saga Le Bourdelles, Habib Ghnaya, Delphine Bolle, Jonathan Farhi, Anne Besançon, Nathalie Denizon, Mustapha Alani
Publikováno v:
Experimental hematology. 65
Iron overload has been associated with poor overall survival in patients with higher-risk myelodysplastic syndromes after allogeneic hematopoietic stem cell transplantation, but has not been investigated in higher-risk MDS patients treated with hypom